The Conversation (0)
Moore Kuehn, PLLC, a securities and shareholder law firm located on Wall Street, is investigating potential claims against:
The company, its officers, or directors misrepresented and/or failed to disclose that: (1) safety concerns about Xeljanz extended to Rinvoq and other JAK inhibitors; (2) as a result, it was likely that the FDA would require additional safety warnings for Rinvoq and would delay the approval of additional treatment indications for Rinvoq; and (3) therefore, Defendants' statements about the company's business, operations, and prospects lacked a reasonable basis. As a result of the alleged wrongful acts and omissions, AbbVie's securities have experienced a significant decline in market value and AbbVie investors have suffered significant damages.
- International Business Machines Corporation (NYSE: IBM)
Please contact only if you acquired shares before April 4, 2017 .
After the close of the market on October 16, 2018, IBM revealed a shortfall in revenue and disappointing 3Q2018 growth associated with the Company's Strategic Imperatives and CAMSS lines of business, particularly its Cloud business line.
On October 20, 2021 , after the close of the market, the Company issued a press release announcing its 3Q2021 results. The Company announced total revenues for the quarter of $17.62 billion , a shortfall of $191.84 million based on analyst estimates. The main culprit was the Cloud & Cognitive Software segment, which had revenues of $5.69 billion , a shortfall of approximately $80 million based on analyst estimates of $5.77 billion . Over 42% of the $191 million shortfall was attributable to the Company's Cloud & Cognitive Software segment – where most of the strategic revenue produced by the fraudulent scheme and wrongful reclassification of revenues from non-strategic to strategic historically went.
Shareholders of ABBV or IBM should contact Fletcher Moore, Esq. by email at fmoore@moorekuehn.com or telephone at (212) 709-8245 .
Moore Kuehn is a New York-based law firm with attorneys representing investors, stockholders, unitholders, and consumers. Attorney advertising. Prior results do not guarantee similar outcomes.
Moore Kuehn, PLLC
Fletcher Moore, Esq.
30 Wall Street, 8 th Floor
New York , New York 10005
fmoore@moorekuehn.com
(212) 709-8245
View original content to download multimedia: https://www.prnewswire.com/news-releases/moore-kuehn-pllc-encourages-investors-of-abbvie-inc-or-international-business-machines-corporation-to-contact-law-firm-301525417.html
SOURCE Moore Kuehn, PLLC
